Microscopic polyangiitis is an autoimmune disease characterized by a systemic, pauci-immune, necrotizing, small-vessel vasculitis without clinical or pathological evidence of granulomatous inflammation. Clinical features may include constitutional symptoms like fever, arthralgia, myalgia, loss of appetite, weight loss and fatigue. A variety of organs can be affected, which causes a wide range of symtoms such as cough, shortness of breath, hemoptysis (coughing up of blood), symtoms of kidney failure, skin manifestations (palpable purpura and livedo racemosa), seizures or peripheral neuropathy, abdominal pain The kidneys are affected in up to 80% of cases with signs of blood and protein in the urine and the injury can lead to either rapidly or slowly progressive kidney failure. The lungs are affected in 20-50% of cases with findings of pulmonary hemorrhage, or chronic pulmonary fibrosis leading to respiratory failure. While the mechanism of the disease has yet to be fully elucidated, the leading hypothesis is that AAV (ANCA Associated Vasculitis) develops in patients with a genetic predisposition when an unknown cause triggers the production of p-ANCA. These antibodies will circulate at low levels until an environmental trigger—such as infection, malignancy, or drug therapy, causes the upregulation of neutrophils. The neutrophils bind to p-ANCAs and subsequently release inflammatory cytokines, reactive oxygen species and lytic enzymes that cause endothelial injury resulting to inflammation and necrosis of the small vessels. The damage that is caused in the kidneys is specifically called necrotizing and crescentic glomerulonephritis. Laboratory tests may reveal an increased sedimentation rate, elevated CRP and anemia. Kidney impairment will result to elevated creatinine in the blood and the detection of protein and red blood cells in the urine.
László Forró, Arnaud Magrez, Andras Kis, Balazs Sipos, Jin Won Seo, Martial Duchamp, Neven Barisic